Search clinical trials for: 90Y-epratuzumab tetraxetan
Total 1143 results
-
Seoul National University HospitalCompletedNeurogenic Bladder | Detrusor Overactivity | Detrusor UnderactivityKorea, Republic of
-
The Christie NHS Foundation TrustBayerCompletedFollicular LymphomaUnited Kingdom, France
-
Genentech, Inc.Completed
-
Hoffmann-La RocheCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Urovant Sciences GmbHCompletedOveractive Bladder With Urge Urinary IncontinenceUnited States
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Tianjin Medical University Cancer Institute and...Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHER2+ Early or Locally Advanced Breast Cancer
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruitingMetastatic Breast CancerSpain
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdCompletedSimilarity of Pharmacokinetics and SafetyChina
-
Fudan UniversityRecruiting
-
Tufts Medical CenterSpectrum Pharmaceuticals, IncTerminatedMultiple MyelomaUnited States
-
O'Dorisio, M SNational Cancer Institute (NCI)CompletedSarcoma | Unspecified Childhood Solid Tumor, Protocol Specific | Brain and Central Nervous System Tumors | Neuroblastoma | Pheochromocytoma | Islet Cell Tumor | Gastrointestinal Carcinoid TumorUnited States
-
Hoffmann-La RocheActive, not recruiting
-
McGill UniversityRecruitingHeart Failure | Chronic Obstructive Pulmonary Disease | Interstitial Lung DiseaseCanada
-
McGill UniversityRecruitingHeart Failure | Chronic Obstructive Pulmonary Disease | Interstitial Lung DiseaseCanada
-
AbbVieCompletedHealthy VolunteerUnited States
-
University Hospital TuebingenHaag-Streit AGCompleted
-
PfizerCompletedOveractive Bladder SyndromeUnited States
-
PfizerCompleted
-
Novartis PharmaceuticalsActive, not recruitingAdvanced HER2+Breast CancerBelgium, France, China, Italy, Spain, Malaysia, United States, Turkey
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
Universidade do PortoLudwig-Maximilians - University of Munich; Fundação para a Ciência e a Tecnologia and other collaboratorsRecruitingCardiopulmonary ResuscitationPortugal
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
PfizerCompleted
-
PfizerCompletedOveractive Bladder SyndromeGermany
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Waldenström Macroglobulinemia | Post-transplant Lymphoproliferative Disorder | Stage III Adult Burkitt Lymphoma | Stage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Burkitt Lymphoma | Stage IV Adult Diffuse...United States
-
AC Camargo Cancer CenterRecruitingBreast Neoplasms | HER2-positive Breast Cancer | Circulating Tumor CellBrazil
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.TerminatedMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | HER2-Positive Breast CarcinomaUnited States
-
Urovant Sciences GmbHIon Channel InnovationsCompletedOveractive BladderUnited States
-
College of CharlestonCompletedMuscle FatigueUnited States
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseCanada, United States
-
Dartmouth-Hitchcock Medical CenterAerasCompleted
-
The Methodist Hospital Research InstituteAstraZenecaRecruitingBreast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterMuhimbili University of Health and Allied SciencesCompleted
-
Astellas Pharma IncTerminatedAdvanced Hepatocellular Carcinoma (HCC)Korea, Republic of, Belgium, United States, Hong Kong, Singapore, Taiwan, Germany, Spain, France, Italy
-
Hoffmann-La RocheActive, not recruitingSolid TumorKorea, Republic of, China, France, Portugal, Spain, Brazil, Germany, Italy, Peru, Russian Federation, Japan, Ukraine, Costa Rica, Mexico, Poland
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine
-
Abion IncCompletedSolid TumorKorea, Republic of
-
Lawson Health Research InstituteCompletedUrinary Bladder, Neurogenic
-
National Institute of Allergy and Infectious Diseases...Completed
-
Henan Cancer HospitalWithdrawnBreast Cancer | HER2-positive Breast CancerChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 PositiveUnited States
-
Henan Cancer HospitalRecruitingBreast Cancer,Her2 PositiveChina
-
OHSU Knight Cancer InstituteOregon Health and Science University; Boston Scientific CorporationCompleted
-
Astellas Pharma IncCompletedAdrenocortical CarcinomaUnited States, France, Netherlands, Italy, Canada, Germany, Australia, Poland, United Kingdom
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseUnited States, Canada
-
Millennium Pharmaceuticals, Inc.Completed